{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:46:18Z","timestamp":1784069178419,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["IP-2019-04-6100"],"award-info":[{"award-number":["IP-2019-04-6100"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pnpbp.2024.111086","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:39:29Z","timestamp":1720690769000},"page":"111086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association between reduced plasma BDNF concentration and MMSE scores in both chronic schizophrenia and mild cognitive impairment"],"prefix":"10.1016","volume":"134","author":[{"given":"Martin","family":"Gredicak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matea","family":"Nikolac Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Nedic Erjavec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kozumplik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravka","family":"Svob Strac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nela","family":"Pivac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111086_bb0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3934\/Neuroscience.2023002","article-title":"Brain-derived neurotrophic factor (BDNF) in schizophrenia research: a quantitative review and future directions","volume":"10","author":"Ahmad","year":"2023","journal-title":"AIMS Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2014.12.069","article-title":"Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a Meta-analysis","volume":"226","author":"Ahmed","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41537-021-00149-0","article-title":"Cognitive impairment in schizophrenia: relationships with cortical thickness in Fronto-temporal regions, and Dissociability from symptom severity","volume":"7","author":"Alkan","year":"2021","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0020","series-title":"APA diagnostic and statistical manual of mental disorders","volume":"524","year":"2013"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0025","first-page":"232","article-title":"The impact of aging, psychotic symptoms, medication, and brain-derived neurotrophic factor on cognitive impairment in Japanese chronic schizophrenia patients","volume":"9","author":"Atake","year":"2018","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000339596","article-title":"The reliability and validity of the Mini-mental state examination in the elderly Croatian population","volume":"33","author":"Boban","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0035","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1017\/S0033291719001685","article-title":"Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a Meta-analysis","volume":"49","author":"Bora","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0040","doi-asserted-by":"crossref","DOI":"10.5455\/PCP.20200410093053","article-title":"Differentiating the cognitive impairment of clinically stable schizophrenia from mild cognitive impairment","volume":"30","author":"Charernboon","year":"2020","journal-title":"Psychiatry Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psychres.2011.01.011","article-title":"Effects of antipsychotics on the serum BDNF levels in schizophrenia","volume":"189","author":"Chen","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0050","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1523\/JNEUROSCI.0348-04.2004","article-title":"Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons","volume":"24","author":"Chen","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/9780470751251.ch14","article-title":"Impact of genetic variant BDNF (Val66Met) on brain structure and function","volume":"289","author":"Chen","year":"2008","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11481-012-9382-z","article-title":"Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan","volume":"7","author":"Chen","year":"2012","journal-title":"J. Neuroimmune Pharmacol. Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0065","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1177\/0269881117731169","article-title":"Associations of fatty acids with cognition, psychopathology, and brain-derived neurotrophic factor levels in patients with First-episode schizophrenia and related disorders treated with Paliperidone extended release","volume":"31","author":"Chung","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000478862","article-title":"Plasma BDNF level in major depression: biomarker of the Val66Met BDNF polymorphism and of the clinical course in met carrier patients","volume":"75","author":"Colle","year":"2017","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0075","first-page":"133","article-title":"The BDNF Val66Met Polymorphism Is a Relevant, but Not Determinant, Risk Factor in the Etiology of Neuropsychiatric Disorders - Current Advances in Human Studies: A Systematic Review","volume":"vol. 8","author":"de Assis","year":"2022","journal-title":"Brain Plast. (Amsterdam, Netherlands)"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.638176","article-title":"V the Val66 and Met66 alleles-specific expression of BDNF in human muscle and their metabolic responsivity","volume":"14","author":"de Assis","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0085","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4088\/JCP.09l05388","article-title":"Lack of association between serum brain-derived neurotrophic factor levels and improvement of schizophrenia symptoms in a double-blind, randomized, placebo-controlled trial of Memantine as adjunctive therapy to clozapine","volume":"71","author":"de Lucena","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114772","article-title":"Reduced plasma BDNF concentration and cognitive decline in veterans with PTSD","volume":"316","author":"Domitrovic Spudic","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jpsychires.2021.04.026","article-title":"Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics","volume":"138","author":"Dong","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF Val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0110","series-title":"Structured Clinical Interview for DSM-5 -Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV)","author":"First","year":"2015"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0120","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1590\/1980-57642021dn15-040009","article-title":"Clock drawing test: comparison between the Pfizer and the Shulman systems","volume":"15","author":"Graeff","year":"2021","journal-title":"Dement. Neuropsychol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0130","series-title":"The Role of Brain-Derived Neurotrophic Factor in Psychiatric Disorders","author":"Gupta","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0135","first-page":"21","article-title":"Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients","volume":"22","author":"Hori","year":"2007","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/08039488.2017.1340518","article-title":"Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study","volume":"71","author":"Kudlek Mikulic","year":"2017","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12031-012-9750-4","article-title":"Association between BDNF Val66Met polymorphism and cognitive performance in antipsychotic-Na\u00efve patients with schizophrenia","volume":"47","author":"Lu","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0155","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: Aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0160","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00406-011-0189-3","article-title":"BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects","volume":"261","author":"Minelli","year":"2011","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20032111","article-title":"The effects of treatment in psychotic disorders-changes in BDNF levels and clinical outcomes: systematic review","volume":"20","author":"Mosio\u0142ek","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020257","article-title":"Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer's disease (AD): a systematic review and Meta-analysis","volume":"20","author":"Ng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0185","article-title":"BDNF as a biomarker of cognition in schizophrenia\/psychosis: an updated review","volume":"12","author":"Nieto","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030570","article-title":"Relationship between brain-derived neurotrophic factor and cognitive decline in patients with mild cognitive impairment and dementia","volume":"13","author":"Nikolac Perkovic","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0195","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mp.2015.152","article-title":"BDNF Val66Met genotype determines Hippocampus-dependent behavior via sensitivity to glucocorticoid signaling","volume":"21","author":"Notaras","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brainresbull.2009.06.022","article-title":"The effect of depression, BDNF gene Val66met polymorphism and gender on serum BDNF levels","volume":"81","author":"Ozan","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0205","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1461145709991015","article-title":"Decreased BDNF levels in CSF of drug-naive First-episode psychotic subjects: correlation with plasma BDNF and psychopathology","volume":"13","author":"Pillai","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0215","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3325\/cmj.2009.50.43","article-title":"Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants","volume":"50","author":"Pivac","year":"2009","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0225","doi-asserted-by":"crossref","first-page":"110452","DOI":"10.1016\/j.pnpbp.2021.110452","article-title":"The association between BDNF C270T genetic variants and smoking in patients with mental disorders and in healthy controls","volume":"113","author":"Pivac","year":"2022","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0230","doi-asserted-by":"crossref","first-page":"17989","DOI":"10.1038\/srep17989","article-title":"A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays","volume":"5","author":"Polacchini","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","article-title":"Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies","volume":"169","author":"Rodriguez","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2012.10.020","article-title":"Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia","volume":"143","author":"Rodriguez-Jimenez","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2021.05.025","article-title":"Effects of physical exercise on plasma brain-derived neurotrophic factor in neurodegenerative disorders: a systematic review and Meta-analysis of randomized controlled trials","volume":"128","author":"Ruiz-Gonz\u00e1lez","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0250","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-021-05790-2","article-title":"Distinct Association of Plasma BDNF concentration and cognitive function in depressed patients treated with Vortioxetine or escitalopram","volume":"238","author":"Sagud","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0255","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U","article-title":"Clock-drawing: is it the ideal cognitive screening test?","volume":"15","author":"Shulman","year":"2000","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12040414","article-title":"Peripheral blood levels of brain-derived neurotrophic factor in patients with First episode psychosis: a systematic review and Meta-analysis","volume":"12","author":"Singh","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/ijmr.IJMR_1566_17","article-title":"Association between reduced brain-derived neurotrophic factor Concentration & Coronary Heart Disease","volume":"150","author":"Sustar","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0270","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12888-019-2231-3","article-title":"Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0275","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1601-183X.2010.00579.x","article-title":"Plasma BDNF concentration, Val66Met genetic variant and depression-related personality traits","volume":"9","author":"Terracciano","year":"2010","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0280","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.schres.2006.03.021","article-title":"The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model","volume":"85","author":"van der Gaag","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0285","article-title":"European psychiatric association guidance on assessment of cognitive impairment in schizophrenia","volume":"65, e58","author":"Vita","year":"2022","journal-title":"Eur. Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.pnpbp.2024.111086_bb0290","first-page":"345","article-title":"Benzodiazepines in combination with antipsychotic drugs for schizophrenia: GABA-ergic targeted therapy","volume":"29","author":"W\u0142odarczyk","year":"2017","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0295","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.4103\/0366-6999.241802","article-title":"Effects of risperidone and Paliperidone on brain-derived neurotrophic factor and N400 in First-episode schizophrenia","volume":"131","author":"Wu","year":"2018","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.105121","article-title":"BDNF affects the mediating effect of negative symptoms on the relationship between age of onset and cognition in patients with chronic schizophrenia","volume":"125","author":"Xu","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2024.111086_bb0305","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/13651501003748560","article-title":"A close correlation between plasma and serum levels of brain-derived neurotrophic factor (BDNF) in healthy volunteers","volume":"14","author":"Yoshimura","year":"2010","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0310","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hup.1257","article-title":"Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in First-episode untreated Japanese schizophrenia patients","volume":"27","author":"Yoshimura","year":"2012","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0315","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00439-012-1150-x","article-title":"Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and Normal controls","volume":"131","author":"Zhang","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.pnpbp.2024.111086_bb0320","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.psyneuen.2014.06.004","article-title":"Gender difference in Association of Cognition with BDNF in chronic schizophrenia","volume":"48","author":"Zhang","year":"2014","journal-title":"Psychoneuroendocrinology"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:30:55Z","timestamp":1728394255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":64,"alternative-id":["S0278584624001544"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111086","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between reduced plasma BDNF concentration and MMSE scores in both chronic schizophrenia and mild cognitive impairment","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111086"}}